SCHEMBL22982531

SCHEMBL22982531

COCc1nn(Cc2ccc3c(c2)CN(C)CC32CC2)cc1C(=O)NCc1c(-n2cc(C)nn2)ccc(OC)c1F

nearest known ligand 0.87

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 14/20 0.87
▸ F11 P03951 8/20 0.87

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29697523 1.00 KLKB1 (0.87) KLKB1F11
SCHEMBL29405504 0.93 F11 (1.00) KLKB1F11
SCHEMBL29407279 0.93 KLKB1 (1.00) KLKB1F11
SCHEMBL29407285 0.91 F11 (0.87) KLKB1F11
SCHEMBL22981502 0.91 F11 (0.85) KLKB1F11
SCHEMBL29407281 0.91 F11 (0.85) KLKB1F11
SCHEMBL29405455 0.90 F11 (1.00) KLKB1F11
SCHEMBL29697514 0.90 KLKB1 (0.84) KLKB1F11
SCHEMBL29407343 0.89 KLKB1 (0.87) KLKB1F11
SCHEMBL29388508 0.87 F11 (0.81) KLKB1F11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4010333-A1 PLASMA KALLIKREIN INHIBITORS Kalvista Pharmaceuticals Limited (GB) 2022-06-15 — — EP disclosed
WO-2021028645-A1 PLASMA KALLIKREIN INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2021-02-18 — — WO disclosed
WO-2021028649-A1 PLASMA KALLIKREIN INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2021-02-18 — — WO disclosed
Send feedback